Is 5 the New 25? Long-Term Oncologic Outcomes From a Phase II, Prospective, 5-Fraction Preoperative Radiation Therapy Trial in Patients With Localized Soft Tissue Sarcoma Advances in Radiation Oncology 1 May 2022;7(3)
Date
05/01/2022DOI
10.1016/j.adro.2021.100850Scopus ID
2-s2.0-85127293946 (requires institutional sign-in at Scopus site) 17 CitationsAuthor List
Bedi M, Singh R, Charlson JA, Kelly T, Johnstone C, Wooldridge A, Hackbarth DA, Moore N, Neilson JC, King DMAuthors
John A. Charlson MD Associate Professor in the Medicine department at Medical College of WisconsinCandice A. Johnstone MD, MPH Professor in the Radiation Oncology department at Medical College of Wisconsin
Tracy R. Kelly MD Associate Professor in the Radiation Oncology department at Medical College of Wisconsin
David M. King MD Chair, Professor in the Orthopaedic Surgery department at Medical College of Wisconsin
John C. Neilson MD Associate Professor in the Orthopaedic Surgery department at Medical College of Wisconsin
Adam Neal Wooldridge MD, MPH Assistant Professor in the Orthopaedic Surgery department at Medical College of Wisconsin
